Nectar Lifesciences Buyback of ā¹81.00 crores approved by the board of directors at the meeting was held on December 3, 2025. Nectar Lifesciences Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ā¹1 each equity share at a price of ā¹27 per Equity Share and for an aggregate amount not exceeding ā¹81.00 crores from the shareholders. Check out Nectar Lifesciences Buyback 2025 details below:
Nectar Lifesciences Buyback About us
Nectar Lifesciences is one of the leading pharmaceutical companies that offers Active Pharmaceutical Ingredients (APIs), particularly cephalosporin antibiotics. Along with APIs, the company also manufactures other medicines like tablets, capsules, suspensions, granules, and injectables. Moreover, it also manufactures empty hard gelatin capsules and products containing phytochemicals and menthol.
Nectar comprises a total of 13 manufacturing facilities for oral and sterile drug production, empty capsule production, and menthol/phytochemicals, located across Punjab and Himachal Pradesh. Furthermore, its manufacturing facilities are approved by international regulators for exports, and it follows the global quality and safety standards (cGMP/EHS), showing strong quality control.
Nectar Lifesciences Buyback History
- N/A
Nectar Lifesciences Buyback 2025 Dates
| Buyback Meeting Date: | December 3, 2025 |
| Buyback Announcement Date: | December 5, 2025 |
| Buyback Record Date: | December 24, 2025 |
| Last Date to Buy Shares: | December 23, 2025 |
| Buyback Open Date: | December 31, 2025 |
| Buyback Close Date: | January 06, 2026 |
| Finalization of Buyback Acceptance: | January 12, 2026 |
Nectar Lifesciences Buyback 2025 Offer Details
Nectar Lifesciences Buyback of 3,00,00,000 equity shares at a price of ā¹27 per equity share. The buyback offers not to exceed ā¹81.00 crores of the total buyback offer size.
| Offer Amount: | ā¹81.00 Crores |
| Number of Shares: | 3,00,00,000 Equity Shares |
| Face Value: | ā¹1 per equity share |
| Buyback Price: | ā¹27 per equity share |
| Listing: | BSE, NSE |
| Buyback Type: | Tender Offer |
| Letter of Offer: | Click Here |
Nectar Lifesciences Buyback 2025 Acceptance Ratio
The investor should buy around 7,407 shares at a current market price of ā¹19 (as of date). The calculation will be ā¹2,00,000 / ā¹27 buyback price = 7,407 shares.
| Acceptance Ratio | Investment | Shares Buyback | Profit |
| 33% | ā¹1,40,733 | 2444 | ā¹19,554 |
| 50% | ā¹1,40,733 | 3704 | ā¹29,632 |
| 75% | ā¹1,40,733 | 5555 | ā¹44,440 |
| 100% | ā¹1,40,733 | 7407 | ā¹59,256 |
Nectar Lifesciences Financial Report
| ā¹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2023 | ā¹1,566.85 | ā¹1,607.54 | ā¹22.46 |
| 2024 | ā¹1,698.66 | ā¹1,680.39 | ā¹5.00 |
| 2025 | ā¹1,674.97 | ā¹1,836.50 | ā¹113.68 |
How to Participate in Nectar Lifesciences Buyback 2025
The investors are eligible for the buyback scheme who have Nectar Lifesciences Buyback shares in their Demat Account as the Record Date. Eligible Share Holders can participate in the Nectar Lifesciences Buyback 2025 scheme as per the opening form by selling their shares. The payment will be given as per the Nectar Lifesciences Buyback accepted shares by the company under the Nectar Lifesciences Buyback scheme.
Nectar Lifesciences Buyback 2025 Registrar
Kfin Technologies Ltd.
KFintech, Tower-B, Plot No 31 & 32,
Financial District, Nanakramguda, Gachibowli,
Hyderabad, Telangana India – 500 032.
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://ipostatus.kfintech.com/
Nectar Lifesciences Buyback 2025 Lead Managers
- Master Capital Services Ltd.
Nectar Lifesciences Company Address
Nectar Lifesciences Limited
Shop No. 5, SL Enclave,
Behind Sohi HP Gas Agency,
Barwala Road,
Dera Bassi, Punjab, 140507
Phone: +91-0172-5078200
Email: [email protected]
Website: https://www.neclife.com/
